Search the Studies

47 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number Title Protocol Status Min-Max Age Institute Keywords
000187-EIAdaptive Optics Imaging of Outer Retinal DiseasesRecruitment has not started21-125 YearsNEI
000108-EIAn Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4Participants currently recruited/enrolled10-125 YearsNEI
000078-EIOcular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors, a Natural History, Observational StudyParticipants currently recruited/enrolled18-125 YearsNEI
20-EI-0163Oral Metformin for Treatment of ABCA4 RetinopathyParticipants currently recruited/enrolled12-125 YearsNEI
20-EI-0052A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular DegenerationParticipants currently recruited/enrolled55-125 YearsNEI
20-EI-0026An Observational Cross-Sectional Study of Virtual Reality Mobility Assessment of Functional Vision in Retinal DiseaseParticipants currently recruited/enrolled5-125 YearsNEI
20-EI-0004Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) TrialParticipants currently recruited/enrolled13-125 YearsNEI
19-EI-0056A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome MeasuresParticipants currently recruited/enrolled12-125 YearsNEI
19-EI-0045A Sub-Study to the Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) (NTMT-01/02E) to Provide the Renexus Implant to Participants who Contributed a Single Eye Randomized to the Sham Procedure in the Enrolling by Invitation21-80 YearsNEI
18-EI-0142A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious UveitisCompleted Study; data analyses ongoing18-125 YearsNEI
18-EI-0068An Investigation of Vitamin A Palmitate Supplementation in Patients with Reticular Pseudodrusen (RPD) and Delayed Dark AdaptationParticipants currently recruited/enrolled50-125 YearsNEI
18-EI-0067An Investigation of Vitamin A Palmitate Supplementation in Patients with Age-Related Macular Degeneration (and without reticular pseudodrusen) and Delayed Dark AdaptationParticipants currently recruited/enrolled50-125 YearsNEI
18-EI-0055A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2No longer recruiting/follow-up only21-79 YearsNEI
18-EI-0046Perception, Sensation, Cognition and Action in HumansParticipants currently recruited/enrolled18-65 YearsNEI
17-EI-0136Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)Enrolling by Invitation21-90 YearsNEI
17-EI-0112A Long-term Follow-up Study of Participants Enrolled in 11-EI-0147: Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration (DA_AMD)Participants currently recruited/enrolled50-125 YearsNEI
17-EI-0071AMD Ryan Initiative StudyParticipants currently recruited/enrolled55-125 YearsNEI
17-EI-0008The Natural History of Geographic Atrophy Associated with Age-Related Macular DegenerationParticipants currently recruited/enrolled55-125 YearsNEI
16-EI-0169A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening UveitisCompleted Study; data analyses ongoing18-125 YearsNEI
16-EI-0159A Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist RanibizumabCompleted Study; data analyses ongoing18-99 YearsNEI
16-EI-0134Studies of the Natural History, Pathogenesis and Outcome of Ocular DisordersParticipants currently recruited/enrolled0-125 YearsNEI
16-EI-0104Clinical and Molecular Studies in Families with Inherited Eye DiseaseParticipants currently recruited/enrolled4-125 YearsNEI
16-EI-0090Natural History of Spinocerebellar Ataxia Type 7 (SCA7)Participants currently recruited/enrolled12-125 YearsNEI
16-EI-0046Uveitis/Intraocular Inflammatory Disease Biobank (iBank)Participants currently recruited/enrolled8-125 YearsNEI
16-EI-0024Rod and Cone Mediated Function in Retinal DiseaseParticipants currently recruited/enrolled5-125 YearsNEI
15-EI-0202Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular DegenerationNo longer recruiting/follow-up only55-125 YearsNEI
15-EI-0128The Genetics of Inherited Eye DiseaseParticipants currently recruited/enrolled0-125 YearsNEI
15-EI-0038A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked RetinoschisisParticipants currently recruited/enrolled18-125 YearsNEI
15-EI-0020Adaptive Optics Retinal ImagingParticipants currently recruited/enrolled12-125 YearsNEI
14-EI-0171The Focal Electro-Oculogram in Macular DiseaseCompleted Study; data analyses ongoing10-125 YearsNEI
14-EI-0064Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye ConditionsParticipants currently recruited/enrolled0-125 YearsNEI
13-EI-0072Microbiome and Ocular Inflammatory DiseaseClinical hold/Recruitment or enrollment suspended18-125 YearsNEI
13-EI-0049Genetics of Uveal ColobomaParticipants currently recruited/enrolled1-125 YearsNEI
12-EI-0203Natural History of ABCA4-Related RetinopathiesNo longer recruiting/follow-up only12-125 YearsNEI
12-EI-0042NEI Intramural Biorepository for Retinal DiseasesParticipants currently recruited/enrolled2-125 YearsNEI
11-EI-0264A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein OcclusionsCompleted Study; data analyses ongoing18-125 YearsNEI
11-EI-0263A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein OcclusionsCompleted Study; data analyses ongoing18-125 YearsNEI
11-EI-0245Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched ControlsParticipants currently recruited/enrolled1-125 YearsNEI
11-EI-0147Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular DegenerationParticipants currently recruited/enrolled50-125 YearsNEI
10-EI-0140Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity, with Evaluation of the ABCA4 GeneParticipants currently recruited/enrolled18-125 YearsNEI
08-EI-0102Screening Protocol for the Evaluation and Diagnosis of Potential Research ParticipantsParticipants currently recruited/enrolled2-125 YearsNEI
08-EI-0043Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-UpNo longer recruiting/follow-up only50-125 YearsNEI
08-EI-0031Visual Motor CoordinationParticipants currently recruited/enrolled18-125 YearsNEI
07-EI-0213LI/NEI RepositoryCompleted Study; data analyses ongoing0-125 YearsNEI
06-EI-0236National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic DiseasesNo longer recruiting/follow-up only2-125 YearsNEI
06-EI-0068The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory DiseaseCompleted Study; data analyses ongoing18-125 YearsNEI
03-EI-0033X-Linked Juvenile Retinoschisis - Clinical and Molecular StudiesParticipants currently recruited/enrolled1-125 YearsNEI